Differences Between Dry and Wet Macular Degeneration and Their Treatments
Which is more dangerous, dry or wet macular degeneration? Dr. Mahmoud Hassan explains the intricate medical distinctions between the two types and the latest biological treatments available for each condition.
Macular Degeneration: Understanding the Differences Between Dry and Wet Forms Affecting Central Vision
Age-related Macular Degeneration (AMD) is one of the leading causes of central vision loss in older adults. This condition affects the macula, a small area in the retina responsible for the sharp, central vision needed for reading and recognizing faces. A key characteristic of this disease is its two main forms: Dry AMD and Wet AMD. This article aims to highlight the fundamental differences between these two types, how they impact central vision, and review the latest available treatment options, all from a precise medical perspective provided by Al Mashreq Eye Center.
What is Dry AMD?
Dry macular degeneration is the most common form of the disease, affecting approximately 80-90% of cases. This type is characterized by the accumulation of small yellow deposits called "drusen" under the retina. Over time, these deposits can cause thinning and deterioration of macular tissues, leading to a gradual loss of central vision. The progression of dry AMD is often slow, and patients may not notice obvious symptoms in its early stages. Potential symptoms include blurry vision, difficulty seeing at night, and the need for brighter light for reading.
What is Wet AMD?
Despite being less common, wet macular degeneration is considered the more severe and rapidly progressing form. This type occurs when abnormal new blood vessels grow under the retina. These blood vessels are weak and fragile, often leaking fluid and blood into the macula area. This leakage can cause rapid swelling and damage to the light-sensitive retinal cells, leading to a sudden and significant loss of central vision. Early warning signs of wet AMD include distorted or wavy lines in the field of vision (metamorphopsia) and the appearance of a blind spot in the center of the visual field.
Key Medical Differences Between the Two Types
The fundamental difference between dry and wet macular degeneration lies in their underlying pathological mechanisms:
- Dry AMD: Characterized by the presence of "drusen" and thinning of retinal tissues, leading to gradual vision loss.
- Wet AMD: Characterized by the growth of abnormal blood vessels under the retina, causing fluid and blood leakage and rapid damage to the macula.
Clinically, the disease often begins as the dry type and may progress to the wet type in a percentage of patients. However, the wet type is responsible for most severe vision loss cases associated with macular degeneration. It is worth noting that accurate diagnosis requires specialized examinations such as fluorescein angiography and optical coherence tomography (OCT), which help determine the type and stage of the disease with precision.
Latest Available Treatments for Macular Degeneration
The field of macular degeneration treatment has witnessed tremendous advancements in recent years, offering effective options to control the disease and preserve vision as much as possible. Dr. Mahmoud Hassan, a key contributor at Al Mashreq Eye Center, explains that treatment varies based on the type of macular degeneration:
Treatment for Dry AMD
Currently, there is no cure for dry macular degeneration, but there are strategies that can help slow the disease's progression in some patients. These strategies include:
- Nutritional Supplements: Studies have shown that taking a specific combination of vitamins and minerals (such as vitamin C, vitamin E, zinc, copper, and lutein) may reduce the risk of dry AMD progressing to the wet type in at-risk individuals.
- Lifestyle Modifications: Quitting smoking, following a healthy diet rich in fruits and vegetables, and maintaining blood pressure and cholesterol within normal ranges all contribute to overall eye health.
Treatment for Wet AMD
Treatment for wet macular degeneration primarily focuses on inhibiting the growth of abnormal blood vessels and reducing leakage. Key treatments include:
- Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Injections: These injections, administered into the vitreous humor of the eye, are the cornerstone of wet AMD treatment. These medications work by inhibiting Vascular Endothelial Growth Factor (VEGF), a protein that plays a key role in the growth and leakage of abnormal blood vessels. Prominent among these drugs are Eylea and Vabysmo. Patients often require a series of regular injections to maintain results. The approximate cost of intravitreal injection (IVI) in Egypt for 2026 starts from EGP 7,000. The approximate cost of Eylea / Lucentis injection in Egypt for 2026 is EGP 9,000. The approximate cost of Vabysmo injection in Egypt for 2026 is EGP 11,000.
- Photodynamic Therapy (PDT): In some cases, this treatment may be used in conjunction with anti-VEGF medications. It involves injecting a light-sensitive drug intravenously, then directing a special laser to the affected area in the eye to activate the drug and destroy abnormal blood vessels.
- Laser Surgery: In very rare cases, a laser may be used to destroy abnormal blood vessels if they are far from the macula's center.
The effectiveness of treatment largely depends on early diagnosis and adherence to the treatment protocol prescribed by the specialized physician. Understanding the differences between dry and wet macular degeneration is the first step towards making the right treatment decisions to protect central vision.
Importance of Regular Follow-up with an Ophthalmologist
Dr. Mahmoud Hassan emphasizes that regular follow-up with a specialized retina ophthalmologist is crucial, especially for those at risk of macular degeneration or who have already been diagnosed. Regular examinations, such as fundus examinations using modern techniques like OCT, help in the early detection of any changes, whether in the form of dryness or progression to the wet type, allowing for timely therapeutic intervention. You can follow more valuable medical information and advice via .
For reservations and inquiries: 01002310813
Articles you might like to read
- Treatment of Proliferative Diabetic Retinopathy (PDR) with Argon Laser and Combined Injection Sessions
- Preventing Retinal Detachment in the Second Eye: Scleral Examination and Buckle
Frequently Asked Questions
ما هو التحلل البقعي المرتبط بالعمر (AMD) وما هي أنواعه الرئيسية؟
التحلل البقعي المرتبط بالعمر (AMD) هو أحد أبرز أسباب فقدان البصر المركزي لدى كبار السن، ويؤثر على الماكولا المسؤولة عن الرؤية الحادة. له نوعان رئيسيان: التحلل البقعي الجاف (Dry AMD) والتحلل البقعي الرطب (Wet AMD).
ما الفرق بين التحلل البقعي الجاف والرطب من حيث الآلية المرضية والأعراض؟
التحلل البقعي الجاف يتميز بتراكم ترسبات صفراء (دروزن) تحت الشبكية وترقق الأنسجة، مما يؤدي إلى فقدان تدريجي للرؤية. أما التحلل البقعي الرطب فيحدث بسبب نمو أوعية دموية جديدة غير طبيعية تحت الشبكية تتسرب منها السوائل والدم، مسببة فقدانًا مفاجئًا وحادًا للرؤية المركزية، وقد تظهر أعراض مثل اعوجاج الرؤية.
ما هي خيارات علاج التحلل البقعي الجاف؟
لا يوجد علاج شافٍ للتحلل البقعي الجاف حاليًا، ولكن يمكن إبطاء تقدمه من خلال تناول مكملات غذائية معينة (مثل فيتامين C، E، الزنك، النحاس، واللوتين) وتعديلات في نمط الحياة كالإقلاع عن التدخين واتباع نظام غذائي صحي.
ما هي العلاجات الرئيسية للتحلل البقعي الرطب؟
يعتمد علاج التحلل البقعي الرطب بشكل أساسي على حقن الأدوية المضادة لعامل نمو البطانة الوعائية (Anti-VEGF) داخل الجسم الزجاجي للعين، مثل إيليا (Eylea) وفابيسمو (Vabysmo)، والتي تهدف إلى إيقاف نمو الأوعية الدموية غير الطبيعية وتقليل التسرب. قد يُستخدم العلاج الضوئي الديناميكي (PDT) أو الجراحة بالليزر في حالات نادرة.
لماذا تعتبر المتابعة الدورية مع طبيب العيون مهمة لمرضى التحلل البقعي؟
المتابعة الدورية مع طبيب شبكية العيون المتخصص أمر حيوي للكشف المبكر عن أي تغيرات، سواء في شكل جفاف أو تطور نحو النوع الرطب، مما يتيح التدخل العلاجي في الوقت المناسب ويساعد في الحفاظ على البصر قدر الإمكان.